Next-generation sequencing role in pharmacogenetics and pharmacogenomics
Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...
top of page
IVD Development
Quality and regulatory excellence.
Quality Management
Our adherence to ISO 13485 underscores our dedication to excellence and safety, guaranteeing that our processes align with the most stringent industry benchmarks. This commitment not only facilitates a seamless interaction with regulatory bodies but also accelerates the approval and market introduction of our devices, ensuring they are swiftly available to healthcare professionals.
Regulatory & Market Navigation
Our team is versed in the intricacies of global regulatory frameworks, ensuring our devices meet the most rigorous standards, including the In Vitro Diagnostic Regulation (IVDR). Our regulatory strategy is built on proactive engagement with regulatory bodies, notified bodies and end users. This approach not only ensures our devices are consistently compliant but also streamlines their path to market, thereby facilitating quicker access for healthcare providers and enhancing patient care.
Range of Technologies
Extensive comprehension of disease mechanisms, biomarker discovery, and assay optimisation across diverse methodologies, including immunoassays, biochemical assays, nucleic acid amplification techniques, and next-generation sequencing (NGS).
Collaboration in Research
Bringing together researchers, industry partners, and healthcare professionals to push the boundaries of genetic and diagnostic research, accelerating the discovery of groundbreaking diagnostics to meet global health challenges.
bottom of page